Article Details
Retrieved on: 2024-02-29 16:25:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer Inc, has released promising top-line data for its Abrysvo vaccine, demonstrating high efficacy against respiratory syncytial virus (RSV) in ...
Article found on: www.infectioncontroltoday.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here